Home Companies Marea Therapeutics COMPANY
Clinical Phase 2
8 open jobs · last seen Oct 23, 2026 · 6 sources
Profile checked Oct 10, 2026
Keywords: Hypertriglyceridemia Acromegaly MAR001 MAR002
Hiring Title Location (from posting) Employer posted First seen Vice President, Bioprocess and Analytical Development South San Francisco, CA Oct 2, 2026 Oct 5, 2026 Associate Director, Device Development South San Francisco Sep 30, 2026 Oct 5, 2026 Senior Clinical Trial Manager South San Francisco Sep 28, 2026 Oct 5, 2026 Director, Downstream Process Development South San Francisco Sep 10, 2026 Oct 5, 2026 Director, Biostatistics South San Francisco Sep 10, 2026 Oct 5, 2026
See all 8 jobs
At a glance HQ San Francisco, CA source Stage Clinical Phase 2 Latest trial Phase 2: A Study to Evaluate MAR002 for Acromegaly (Jul 23, 2026) source Timeline Oct 5, 2026 Board tracked Radar started tracking this company’s job board (8 open jobs at last check). source ↗ Jul 23, 2026 Trial start Phase 2: A Study to Evaluate MAR002 for Acromegaly source ↗ Sep 26, 2025 Trial start Phase 2: A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol source ↗ Aug 11, 2025 Trial start Phase 1: Study of MAR002 in Healthy Men source ↗ Jun 30, 2025 Trial start Phase 2: Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol source ↗ Jul 22, 2023 Trial start Phase 1/Phase 2: Study of MAR001 in Adults With Metabolic Dysfunction source ↗ Upcoming milestones 2027-08 (ESTIMATED) · Phase 2 · A Study to Evaluate MAR002 for Acromegaly · NCT07641179 2027-11 (ESTIMATED) · Phase 2 · Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol · NCT07028749 Estimated primary completion per ClinicalTrials.gov. Dates move.
Open jobs 8 Title Location (from posting, not HQ) Employer posted First seen Level Vice President, Bioprocess and Analytical Development South San Francisco, CA Oct 2, 2026 Oct 5, 2026 Executive Description Associate Director, Device Development South San Francisco Sep 30, 2026 Oct 5, 2026 Senior Description Senior Clinical Trial Manager South San Francisco Sep 28, 2026 Oct 5, 2026 Senior Description Director, Downstream Process Development South San Francisco Sep 10, 2026 Oct 5, 2026 Senior Description Director, Biostatistics South San Francisco Sep 10, 2026 Oct 5, 2026 Senior Description Senior Director, Data Management South San Francisco Sep 10, 2026 Oct 5, 2026 Senior Description Senior Director, Regulatory CMC South San Francisco Jul 22, 2026 Oct 5, 2026 Senior Description Senior Manager, Regulatory Affairs South San Francisco Jul 20, 2026 Oct 5, 2026 Senior Description
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Clinical trials (lead sponsor) 5 Record Title Phase Status Start Primary completion NCT07641179 A Study to Evaluate MAR002 for Acromegaly Phase 2 Recruiting Jul 23, 2026 2027-08 (estimated) NCT07028749 Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol Phase 2 Recruiting Jun 30, 2025 2027-11 (estimated) NCT07195175 Study of MAR002 in Healthy Men Phase 1 Recruiting Aug 11, 2025 2026-07 (estimated) NCT05896254 Study of MAR001 in Adults With Metabolic Dysfunction Phase 1/Phase 2 Completed Jul 22, 2023 Dec 13, 2024 (actual) NCT07199309 A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol Phase 2 Recruiting Sep 26, 2025 2026-07 (estimated)
Raises and investors new Form D raises come from the company’s own SEC filing (last 2 years).
Investor Listed in the portfolio of Sofinnova Investments (captured Oct 12, 2026). portfolio page ↗